The next stop is a full House vote, then the governor’s desk, for a bill to cap the out-of-pocket cost of insulin at $35/month until January 2025. With the U.S. Senate agreeing to the same insulin cost cap for Medicare patients, followed by drug maker Eli Lilly voluntarily capping its own insulin price, $35/month is rapidly becoming the new normal. Click play to hear Corwin Haeck’s report. (PHOTO: AP/Rich Pedroncelli)
